POPULARITY
11 episodes with series brain channel health
11 episodes with series brain channel health
6 episodes with series brain channel health
6 episodes with series brain channel health
2 episodes with series brain channel health
3 episodes with series brain channel health
2 episodes with series brain channel health
2 episodes with series brain channel health
2 episodes with series brain channel health
Claudia H. Kawas, M.D., addresses Alzheimer's disease and related conditions in older adults, noting the challenge of accurate diagnosis and the resemblance of other brain conditions to Alzheimer's. She introduces "resistance" and "resilience," explaining how some individuals remain cognitively intact despite brain changes. Kawas suggests declining dementia risk due to improved vascular health management, emphasizing the complexity of cognitive decline and the need for further research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 39532]
Claudia H. Kawas, M.D., addresses Alzheimer's disease and related conditions in older adults, noting the challenge of accurate diagnosis and the resemblance of other brain conditions to Alzheimer's. She introduces "resistance" and "resilience," explaining how some individuals remain cognitively intact despite brain changes. Kawas suggests declining dementia risk due to improved vascular health management, emphasizing the complexity of cognitive decline and the need for further research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 39532]
Claudia H. Kawas, M.D., addresses Alzheimer's disease and related conditions in older adults, noting the challenge of accurate diagnosis and the resemblance of other brain conditions to Alzheimer's. She introduces "resistance" and "resilience," explaining how some individuals remain cognitively intact despite brain changes. Kawas suggests declining dementia risk due to improved vascular health management, emphasizing the complexity of cognitive decline and the need for further research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 39532]
Claudia H. Kawas, M.D., addresses Alzheimer's disease and related conditions in older adults, noting the challenge of accurate diagnosis and the resemblance of other brain conditions to Alzheimer's. She introduces "resistance" and "resilience," explaining how some individuals remain cognitively intact despite brain changes. Kawas suggests declining dementia risk due to improved vascular health management, emphasizing the complexity of cognitive decline and the need for further research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 39532]
Claudia H. Kawas, M.D., addresses Alzheimer's disease and related conditions in older adults, noting the challenge of accurate diagnosis and the resemblance of other brain conditions to Alzheimer's. She introduces "resistance" and "resilience," explaining how some individuals remain cognitively intact despite brain changes. Kawas suggests declining dementia risk due to improved vascular health management, emphasizing the complexity of cognitive decline and the need for further research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 39532]
Claudia H. Kawas, M.D., addresses Alzheimer's disease and related conditions in older adults, noting the challenge of accurate diagnosis and the resemblance of other brain conditions to Alzheimer's. She introduces "resistance" and "resilience," explaining how some individuals remain cognitively intact despite brain changes. Kawas suggests declining dementia risk due to improved vascular health management, emphasizing the complexity of cognitive decline and the need for further research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 39532]
Claudia H. Kawas, M.D., addresses Alzheimer's disease and related conditions in older adults, noting the challenge of accurate diagnosis and the resemblance of other brain conditions to Alzheimer's. She introduces "resistance" and "resilience," explaining how some individuals remain cognitively intact despite brain changes. Kawas suggests declining dementia risk due to improved vascular health management, emphasizing the complexity of cognitive decline and the need for further research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 39532]
Claudia H. Kawas, M.D., addresses Alzheimer's disease and related conditions in older adults, noting the challenge of accurate diagnosis and the resemblance of other brain conditions to Alzheimer's. She introduces "resistance" and "resilience," explaining how some individuals remain cognitively intact despite brain changes. Kawas suggests declining dementia risk due to improved vascular health management, emphasizing the complexity of cognitive decline and the need for further research. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 39532]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
Manny Ohonme received his first pair of shoes at the age of nine. The gift left a lasting impression on the young Nigerian boy. Today, Ohnome is the founder of Samaritan's Feet, an organization dedicated to providing shoes to children in need. In this interview, he shares his personal story and explains how providing shoes is not just about comfort but a way to foster equity, health, education, and hope. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 36268]
How does a hospital system quickly adapt to manage a crisis? Patty Maysent, CEO of UC San Diego Health, describes how a team approach, embracing telehealth, scalable testing, and communication have aided in creating effective and safe systems during the COVID-19 pandemic. She also discusses her background as a competitive swimmer and how the athlete's mindset can be a useful tool in these stressful times. Series: "Brain Channel" [Health and Medicine] [Show ID: 35946]
How does a hospital system quickly adapt to manage a crisis? Patty Maysent, CEO of UC San Diego Health, describes how a team approach, embracing telehealth, scalable testing, and communication have aided in creating effective and safe systems during the COVID-19 pandemic. She also discusses her background as a competitive swimmer and how the athlete's mindset can be a useful tool in these stressful times. Series: "Brain Channel" [Health and Medicine] [Show ID: 35946]
During a pandemic, the strain on healthcare professionals extends beyond the hours they see patients. Steven Garfin, MD, orthopedic surgeon and dean of the UC San Diego School of medicine, joins William Mobley, MD, PhD to discuss how COVID-19 has changed the day to day lives of those on the front line as well as the perspective of future medical students. Series: "Brain Channel" [Health and Medicine] [Show ID: 35863]
During a pandemic, the strain on healthcare professionals extends beyond the hours they see patients. Steven Garfin, MD, orthopedic surgeon and dean of the UC San Diego School of medicine, joins William Mobley, MD, PhD to discuss how COVID-19 has changed the day to day lives of those on the front line as well as the perspective of future medical students. Series: "Brain Channel" [Health and Medicine] [Show ID: 35863]
In times of stress, anxiety, and isolation finding effective strategies to understand our emotions and how we relate to the world at large often brings comfort. Mindfulness, meditation, and compassion have long been championed as helpful strategies but how do they impact our well being, if at all? Fadel Zeidan joins William Mobley to discuss his work applying scientific methods to these practices to quantify and discover how and why they work. Series: "Brain Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 35824]
In times of stress, anxiety, and isolation finding effective strategies to understand our emotions and how we relate to the world at large often brings comfort. Mindfulness, meditation, and compassion have long been championed as helpful strategies but how do they impact our well being, if at all? Fadel Zeidan joins William Mobley to discuss his work applying scientific methods to these practices to quantify and discover how and why they work. Series: "Brain Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 35824]
In times of stress, anxiety, and isolation finding effective strategies to understand our emotions and how we relate to the world at large often brings comfort. Mindfulness, meditation, and compassion have long been championed as helpful strategies but how do they impact our well being, if at all? Fadel Zeidan joins William Mobley to discuss his work applying scientific methods to these practices to quantify and discover how and why they work. Series: "Brain Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 35824]
In times of stress, anxiety, and isolation finding effective strategies to understand our emotions and how we relate to the world at large often brings comfort. Mindfulness, meditation, and compassion have long been championed as helpful strategies but how do they impact our well being, if at all? Fadel Zeidan joins William Mobley to discuss his work applying scientific methods to these practices to quantify and discover how and why they work. Series: "Brain Channel" [Health and Medicine] [Humanities] [Science] [Show ID: 35824]
David M. Holtzman, MD of the Washington University School of Medicine discusses the mechanisms underlying neurodegeneration and how microglia and specific microglial genes such as TREM2 influence neurodegeneration in the setting of Aβ and tau pathology. Learn how this line of study may lead to new therapeutics and diagnostic testing for Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35262]
David M. Holtzman, MD of the Washington University School of Medicine discusses the mechanisms underlying neurodegeneration and how microglia and specific microglial genes such as TREM2 influence neurodegeneration in the setting of Aβ and tau pathology. Learn how this line of study may lead to new therapeutics and diagnostic testing for Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35262]
David M. Holtzman, MD of the Washington University School of Medicine discusses the mechanisms underlying neurodegeneration and how microglia and specific microglial genes such as TREM2 influence neurodegeneration in the setting of Aβ and tau pathology. Learn how this line of study may lead to new therapeutics and diagnostic testing for Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35262]
David M. Holtzman, MD of the Washington University School of Medicine discusses the mechanisms underlying neurodegeneration and how microglia and specific microglial genes such as TREM2 influence neurodegeneration in the setting of Aβ and tau pathology. Learn how this line of study may lead to new therapeutics and diagnostic testing for Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 35262]
More than 5 million Americans are currently diagnosed with Alzheimer’s disease, and that number is expected to triple by 2050, without prevention or cure. By 2060, the number of Latinos in the United States living with Alzheimer’s disease is projected to increase 832 percent — from 379,000 in 2012, to more than 3.5 million. Find out what UC San Diego is doing to both serve this community and catalyze the research careers of investigators from underrepresented groups. Series: "Brain Channel" [Health and Medicine] [Show ID: 34417]
More than 5 million Americans are currently diagnosed with Alzheimer’s disease, and that number is expected to triple by 2050, without prevention or cure. By 2060, the number of Latinos in the United States living with Alzheimer’s disease is projected to increase 832 percent — from 379,000 in 2012, to more than 3.5 million. Find out what UC San Diego is doing to both serve this community and catalyze the research careers of investigators from underrepresented groups. Series: "Brain Channel" [Health and Medicine] [Show ID: 34417]
More than 5 million Americans are currently diagnosed with Alzheimer’s disease, and that number is expected to triple by 2050, without prevention or cure. By 2060, the number of Latinos in the United States living with Alzheimer’s disease is projected to increase 832 percent — from 379,000 in 2012, to more than 3.5 million. Find out what UC San Diego is doing to both serve this community and catalyze the research careers of investigators from underrepresented groups. Series: "Brain Channel" [Health and Medicine] [Show ID: 34417]
More than 5 million Americans are currently diagnosed with Alzheimer’s disease, and that number is expected to triple by 2050, without prevention or cure. By 2060, the number of Latinos in the United States living with Alzheimer’s disease is projected to increase 832 percent — from 379,000 in 2012, to more than 3.5 million. Find out what UC San Diego is doing to both serve this community and catalyze the research careers of investigators from underrepresented groups. Series: "Brain Channel" [Health and Medicine] [Show ID: 34417]
Alex Figueroa and Dr. Jose Soria-Lopez discuss clinical symptoms of Alzheimer's Disease and the need to include the Latino community in clinical research. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34416]
Alex Figueroa and Dr. Jose Soria-Lopez discuss clinical symptoms of Alzheimer's Disease and the need to include the Latino community in clinical research. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34416]
Alex Figueroa and Dr. Jose Soria-Lopez discuss clinical symptoms of Alzheimer's Disease and the need to include the Latino community in clinical research. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34416]
Alex Figueroa and Dr. Jose Soria-Lopez discuss clinical symptoms of Alzheimer's Disease and the need to include the Latino community in clinical research. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34416]
Este es el primer episodio en español de la Universidad de San Diego California sobre la investigaciĂłn de la Enfermedad de Alzheimer Demencia en la comunidad latina. En este episodio Alex Figueroa y el Dr. Jose Soria-Lopez conversan sobre los sĂntomas clĂnicos y la necesidad de incluir la comunidad latina en investigaciones clĂnicas sobre esta enfermedad. Se mencionan maneras de combatir la enfermedad y recursos sociales que están disponibles para personas con esta enfermedad y familiares. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34205]
Este es el primer episodio en español de la Universidad de San Diego California sobre la investigaciĂłn de la Enfermedad de Alzheimer Demencia en la comunidad latina. En este episodio Alex Figueroa y el Dr. Jose Soria-Lopez conversan sobre los sĂntomas clĂnicos y la necesidad de incluir la comunidad latina en investigaciones clĂnicas sobre esta enfermedad. Se mencionan maneras de combatir la enfermedad y recursos sociales que están disponibles para personas con esta enfermedad y familiares. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34205]
Este es el primer episodio en español de la Universidad de San Diego California sobre la investigaciĂłn de la Enfermedad de Alzheimer Demencia en la comunidad latina. En este episodio Alex Figueroa y el Dr. Jose Soria-Lopez conversan sobre los sĂntomas clĂnicos y la necesidad de incluir la comunidad latina en investigaciones clĂnicas sobre esta enfermedad. Se mencionan maneras de combatir la enfermedad y recursos sociales que están disponibles para personas con esta enfermedad y familiares. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34205]
Este es el primer episodio en español de la Universidad de San Diego California sobre la investigaciĂłn de la Enfermedad de Alzheimer Demencia en la comunidad latina. En este episodio Alex Figueroa y el Dr. Jose Soria-Lopez conversan sobre los sĂntomas clĂnicos y la necesidad de incluir la comunidad latina en investigaciones clĂnicas sobre esta enfermedad. Se mencionan maneras de combatir la enfermedad y recursos sociales que están disponibles para personas con esta enfermedad y familiares. Series: "Brain Channel" [Health and Medicine] [Science] [Spanish Language] [Show ID: 34205]
There are different types of genetic influences on people's risk of developing Alzheimer's disease. Douglas Galasko, MD, of the UCSD Shiley-Marcos Alzheimer’s Disease Research Center joins William Mobley, MD, PhD to discuss these genes, how they are being studied, and what being a carrier of Alzheimer's associated genes means. Learn more about penetrance and expressivity, genome-wide association studies, and more. Series: "Brain Channel" [Health and Medicine] [Show ID: 33725]
There are different types of genetic influences on people's risk of developing Alzheimer's disease. Douglas Galasko, MD, of the UCSD Shiley-Marcos Alzheimer’s Disease Research Center joins William Mobley, MD, PhD to discuss these genes, how they are being studied, and what being a carrier of Alzheimer's associated genes means. Learn more about penetrance and expressivity, genome-wide association studies, and more. Series: "Brain Channel" [Health and Medicine] [Show ID: 33725]
There are different types of genetic influences on people's risk of developing Alzheimer's disease. Douglas Galasko, MD, of the UCSD Shiley-Marcos Alzheimer’s Disease Research Center joins William Mobley, MD, PhD to discuss these genes, how they are being studied, and what being a carrier of Alzheimer's associated genes means. Learn more about penetrance and expressivity, genome-wide association studies, and more. Series: "Brain Channel" [Health and Medicine] [Show ID: 33725]
There are different types of genetic influences on people's risk of developing Alzheimer's disease. Douglas Galasko, MD, of the UCSD Shiley-Marcos Alzheimer’s Disease Research Center joins William Mobley, MD, PhD to discuss these genes, how they are being studied, and what being a carrier of Alzheimer's associated genes means. Learn more about penetrance and expressivity, genome-wide association studies, and more. Series: "Brain Channel" [Health and Medicine] [Show ID: 33725]
How do you model a disease process that stretches out over 20 years in a way that helps you intervene in that process? In the inaugural Shiley Endowed Lecture, Bradley Hyman, MD, PhD shares his research on the progression of Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33992]
How do you model a disease process that stretches out over 20 years in a way that helps you intervene in that process? In the inaugural Shiley Endowed Lecture, Bradley Hyman, MD, PhD shares his research on the progression of Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33992]
How do you model a disease process that stretches out over 20 years in a way that helps you intervene in that process? In the inaugural Shiley Endowed Lecture, Bradley Hyman, MD, PhD shares his research on the progression of Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33992]
How do you model a disease process that stretches out over 20 years in a way that helps you intervene in that process? In the inaugural Shiley Endowed Lecture, Bradley Hyman, MD, PhD shares his research on the progression of Alzheimer's disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33992]
Michael Rafii, MD, PhD describes the conditions that affect people with Down syndrome including vision issues, hearing issues, hormonal issue, spinal cord issues, sleep apnea, and Alzheimer's disease. He stresses the need for routine medical follow ups with primary care physicians and specialty clinics to make sure all changes in health are addressed. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33603]
Karen Gaffney, advocate and disability champion, discusses her life with Down syndrome. She also talks about the impact that pre natal testing is having on the Down syndrome community and advocates for medical research to focus on the immediate needs such as Alzheimer's disease prevention. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33602]
Michael Rafii, MD, PhD describes the conditions that affect people with Down syndrome including vision issues, hearing issues, hormonal issue, spinal cord issues, sleep apnea, and Alzheimer's disease. He stresses the need for routine medical follow ups with primary care physicians and specialty clinics to make sure all changes in health are addressed. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33603]
Karen Gaffney, advocate and disability champion, discusses her life with Down syndrome. She also talks about the impact that pre natal testing is having on the Down syndrome community and advocates for medical research to focus on the immediate needs such as Alzheimer's disease prevention. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 33602]
The human genome impacts human health and our risk for psychiatric and developmental disorders. Jonathan Sebat, PhD, Director, Beyster Institute for Psychiatric Genomics, Professor of Psychiatry, Cellular & Molecular Medicine, and Pediatrics, UC San Diego School of Medicine joins William Mobley, MD, PhD to give a brief overview of the human genome, the blueprint to human development. Series: "Brain Channel" [Health and Medicine] [Show ID: 33102]
The human genome impacts human health and our risk for psychiatric and developmental disorders. Jonathan Sebat, PhD, Director, Beyster Institute for Psychiatric Genomics, Professor of Psychiatry, Cellular & Molecular Medicine, and Pediatrics, UC San Diego School of Medicine joins William Mobley, MD, PhD to give a brief overview of the human genome, the blueprint to human development. Series: "Brain Channel" [Health and Medicine] [Show ID: 33102]
Jonathan Sebat, PhD, Director, Beyster Institute for Psychiatric Genomics, Professor of Psychiatry, Cellular & Molecular Medicine, and Pediatrics, UC San Diego School of Medicine joins William Mobley, MD, PhD to discuss genetics as they relate to autism and how technology can help pinpoint the genes contributing to the disorder. Series: "Brain Channel" [Health and Medicine] [Show ID: 33065]
Jonathan Sebat, PhD, Director, Beyster Institute for Psychiatric Genomics, Professor of Psychiatry, Cellular & Molecular Medicine, and Pediatrics, UC San Diego School of Medicine joins William Mobley, MD, PhD to discuss genetics as they relate to autism and how technology can help pinpoint the genes contributing to the disorder. Series: "Brain Channel" [Health and Medicine] [Show ID: 33065]
Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]
Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]
Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]
Can we turn off the genes responsible for neurodegenerative diseases? Designer DNA drugs are making this possible. By identifying and targeting the genes that drive disease, scientists are moving closer to treatments for ALS, Huntington's disease, and more. Don W. Cleveland, PhD, Department of Cellular and Molecular Medicine, UC San Diego joins William Mobley, MD, PhD to talk about how these drugs work and how they will impact patient care. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32505]
Joseph G. Gleeson, MD, Rady Professor of Neuroscience at UC San Diego, joins William Mobley, MD, PhD, to discuss his work sequencing DNA to find treatments for neurodevelopmental disorders. Learn more about using a genetic framework to tease out the individual contributors to autism, why implementing rapid DNA sequencing for newborns can make huge impacts, and more. Series: "Brain Channel" [Health and Medicine] [Show ID: 31470]
Joseph G. Gleeson, MD, Rady Professor of Neuroscience at UC San Diego, joins William Mobley, MD, PhD, to discuss his work sequencing DNA to find treatments for neurodevelopmental disorders. Learn more about using a genetic framework to tease out the individual contributors to autism, why implementing rapid DNA sequencing for newborns can make huge impacts, and more. Series: "Brain Channel" [Health and Medicine] [Show ID: 31470]
Jeffrey P. Harris, MD, PhD, FACS joins William Mobley, MD, PhD for a wide-ranging discussion about the field of otolaryngology. With his background in immunology, Dr. Harris has pioneered new methods of drug delivery to the inner ear. As a surgeon, he did the first cochlear implant surgery in San Diego county and continues to work with the technology as it advances. He discusses current treatments for inner ear problems and looks to the future - including treatments for HPV-related facial cancers, regenerating hair cells in cases of hearing loss, the brain's response to cochlear implants and more. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32242]
Jeffrey P. Harris, MD, PhD, FACS joins William Mobley, MD, PhD for a wide-ranging discussion about the field of otolaryngology. With his background in immunology, Dr. Harris has pioneered new methods of drug delivery to the inner ear. As a surgeon, he did the first cochlear implant surgery in San Diego county and continues to work with the technology as it advances. He discusses current treatments for inner ear problems and looks to the future - including treatments for HPV-related facial cancers, regenerating hair cells in cases of hearing loss, the brain's response to cochlear implants and more. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32242]
What is autism? Karen Pierce, PhD, co-director of the UC San Diego Autism Center of Excellence joins William Mobley, MD, PhD to discuss the neurodevelopmental disorder, autism. Watch the entire show to learn about the importance of early detection, creating standardized screenings, the search for diagnostic and prognostic biomarkers, and what parents and pediatricians can do to help children with autism. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32508]
What is autism? Karen Pierce, PhD, co-director of the UC San Diego Autism Center of Excellence joins William Mobley, MD, PhD to discuss the neurodevelopmental disorder, autism. Watch the entire show to learn about the importance of early detection, creating standardized screenings, the search for diagnostic and prognostic biomarkers, and what parents and pediatricians can do to help children with autism. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 32508]
Igor Grant, MD, FRCP(C) pursues research that addresses real world behavioral problems. Studying the intersection of drugs of abuse (primarily methamphetamine) and infection, his work sheds light on the basic mechanisms of injury for people with HIV. He examines inflammation in the context of neurological disorders and measures the impact of chronic stress on Alzheimer's disease caregivers. Dr. Grant joins William Mobley, MD, PhD to discuss his life in science and his fascinating work. Series: "Brain Channel" [Health and Medicine] [Show ID: 32221]
Igor Grant, MD, FRCP(C) pursues research that addresses real world behavioral problems. Studying the intersection of drugs of abuse (primarily methamphetamine) and infection, his work sheds light on the basic mechanisms of injury for people with HIV. He examines inflammation in the context of neurological disorders and measures the impact of chronic stress on Alzheimer's disease caregivers. Dr. Grant joins William Mobley, MD, PhD to discuss his life in science and his fascinating work. Series: "Brain Channel" [Health and Medicine] [Show ID: 32221]
Igor Grant, MD, FRCP(C) pursues research that addresses real world behavioral problems. Studying the intersection of drugs of abuse (primarily methamphetamine) and infection, his work sheds light on the basic mechanisms of injury for people with HIV. He examines inflammation in the context of neurological disorders and measures the impact of chronic stress on Alzheimer's disease caregivers. Dr. Grant joins William Mobley, MD, PhD to discuss his life in science and his fascinating work. Series: "Brain Channel" [Health and Medicine] [Show ID: 32221]
Igor Grant, MD, FRCP(C) pursues research that addresses real world behavioral problems. Studying the intersection of drugs of abuse (primarily methamphetamine) and infection, his work sheds light on the basic mechanisms of injury for people with HIV. He examines inflammation in the context of neurological disorders and measures the impact of chronic stress on Alzheimer's disease caregivers. Dr. Grant joins William Mobley, MD, PhD to discuss his life in science and his fascinating work. Series: "Brain Channel" [Health and Medicine] [Show ID: 32221]
How does the genome impact human health and our risk for psychiatric and developmental disorders? What is the interplay between our genes and our environment? Jonathan Sebat, PhD, Director, Beyster Institute for Psychiatric Genomics, Professor of Psychiatry, Cellular & Molecular Medicine, and Pediatrics, UC San Diego School of Medicine joins William Mobley, MD, PhD to discuss the genetic causes for autism and how technology can help pinpoint those causes and influence potential therapies. Series: "Brain Channel" [Health and Medicine] [Show ID: 31434]
How does the genome impact human health and our risk for psychiatric and developmental disorders? What is the interplay between our genes and our environment? Jonathan Sebat, PhD, Director, Beyster Institute for Psychiatric Genomics, Professor of Psychiatry, Cellular & Molecular Medicine, and Pediatrics, UC San Diego School of Medicine joins William Mobley, MD, PhD to discuss the genetic causes for autism and how technology can help pinpoint those causes and influence potential therapies. Series: "Brain Channel" [Health and Medicine] [Show ID: 31434]
What are the early signs of autism and how is it diagnosed? Doris A. Trauner MD, distinguished professor in the departments of Neurosciences and Pediatrics at the UC San Diego School of Medicine joins William Mobley, MD, PhD to talk about early indicators, the process of obtaining a diagnosis, finding treatable causes, and identifying the most effective interventions. Series: "Brain Channel" [Health and Medicine] [Show ID: 31708]
What are the early signs of autism and how is it diagnosed? Doris A. Trauner MD, distinguished professor in the departments of Neurosciences and Pediatrics at the UC San Diego School of Medicine joins William Mobley, MD, PhD to talk about early indicators, the process of obtaining a diagnosis, finding treatable causes, and identifying the most effective interventions. Series: "Brain Channel" [Health and Medicine] [Show ID: 31708]
What is autism and how can we treat it? Karen Pierce, PhD, co-director of the UC San Diego Autism Center of Excellence joins William Mobley, MD, PhD to define autism and share current research. Learn about the importance of early detection, creating standardized screenings, the search for diagnostic and prognostic biomarkers, and what parents and pediatricians can do to help children with autism. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 31469]
What is autism and how can we treat it? Karen Pierce, PhD, co-director of the UC San Diego Autism Center of Excellence joins William Mobley, MD, PhD to define autism and share current research. Learn about the importance of early detection, creating standardized screenings, the search for diagnostic and prognostic biomarkers, and what parents and pediatricians can do to help children with autism. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 31469]
David Zee, M.D., Professor of Neurology, Ophthalmology, Otolaryngology, Head & Neck Surgery, and Neuroscience, at Johns Hopkins University presents the latest research on Magnetic Vestibular Stimulation (MVS). Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 31382]
While Parkinson’s disease is widely known as a motion disorder, it affects other areas of the brain including cognition. Bill Mobley welcomes Vincent Filoteo in a discussion of his efforts to understand these effects both as early signs of the disease and to devise treatments to ameliorate these cognitive effects. Series: "Brain Channel" [Health and Medicine] [Show ID: 30724]
While Parkinson’s disease is widely known as a motion disorder, it affects other areas of the brain including cognition. Bill Mobley welcomes Vincent Filoteo in a discussion of his efforts to understand these effects both as early signs of the disease and to devise treatments to ameliorate these cognitive effects. Series: "Brain Channel" [Health and Medicine] [Show ID: 30724]
Bill Mobley welcomes epidemiologist Harvey Checkoway in a fascinating discussion about exploring and revealing environmental factors contributing to Parkinson’s Disease and other motion disorders. Series: "Brain Channel" [Health and Medicine] [Show ID: 30530]
Bill Mobley welcomes epidemiologist Harvey Checkoway in a fascinating discussion about exploring and revealing environmental factors contributing to Parkinson’s Disease and other motion disorders. Series: "Brain Channel" [Health and Medicine] [Show ID: 30530]
Inspired by the legacy of his father, boxing legend Archie Moore, Billy Moore has dedicated his life to helping kids find their footing in the world through boxing. His Any Body Can Youth Foundation opens its doors daily to local youth for training, tutoring, and fellowship. Billy Moore sits down with William Mobley, MD, PhD to talk about his father, the foundation, and his vision for helping kids. Series: "Brain Channel" [Health and Medicine] [Show ID: 29375]
Inspired by the legacy of his father, boxing legend Archie Moore, Billy Moore has dedicated his life to helping kids find their footing in the world through boxing. His Any Body Can Youth Foundation opens its doors daily to local youth for training, tutoring, and fellowship. Billy Moore sits down with William Mobley, MD, PhD to talk about his father, the foundation, and his vision for helping kids. Series: "Brain Channel" [Health and Medicine] [Show ID: 29375]
Six in ten people with dementia will wander. Hear about the programs that are available to help bring them home safe. Linda Cho, executive director of Stellar care, joins William Mobley, MD, PhD to discuss the problem of wandering and how to create a home environment that facilitates safety and comfort. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 28834]
Six in ten people with dementia will wander. Hear about the programs that are available to help bring them home safe. Linda Cho, executive director of Stellar care, joins William Mobley, MD, PhD to discuss the problem of wandering and how to create a home environment that facilitates safety and comfort. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 28834]
Jean-Pierre Changeux reflects on his scientific journey and shares insights into his research with Dr. William Mobley. This wide-ranging discussion takes a deeper look into Changeux's early work with bacteria to more recent findings on the chemistry of consciousness. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 29376]
Choosing residential care for a loved one if often a difficult decision. Linda Cho, executive director of Stellar care, joins William Mobley, MD, PhD to talk about the new models of residential care, family involvement, care with dignity and more. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 28955]
Choosing residential care for a loved one if often a difficult decision. Linda Cho, executive director of Stellar care, joins William Mobley, MD, PhD to talk about the new models of residential care, family involvement, care with dignity and more. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 28955]
Steve Hickman, Psy.D., Executive Director of the UC San Diego Center for Mindfulness joins William Mobley, MD, PhD for a discussion of how to be present in the moment and leverage the practice of mindfulness to stay engaged, focused, and fulfilled. Series: "Brain Channel" [Health and Medicine] [Humanities] [Show ID: 25775]
Michael Okun, MD discusses the processes and prospects for deep brain stimulation (DBS). Learn why we apply electricity to the brain, how DBS works, and how we can use DBS to treat conditions such as Parkinson’s Disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 27925]
Michael Okun, MD discusses the processes and prospects for deep brain stimulation (DBS). Learn why we apply electricity to the brain, how DBS works, and how we can use DBS to treat conditions such as Parkinson’s Disease. Series: "Brain Channel" [Health and Medicine] [Science] [Show ID: 27925]
© 2020-2025 Ivy Podcast Discovery LLC
